Citations (90)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (10)
Pooria Safarzadeh Kozani, Pouya Safarzadeh Kozani & Fatemeh Rahbarizadeh. (2022) Addressing the obstacles of CAR T cell migration in solid tumors: wishing a heavy traffic. Critical Reviews in Biotechnology 42:7, pages 1079-1098.
Read now
Read now
Zhifei Xu, Ying Jin, Zizheng Gao, Yan Zeng, Jiangxia Du, Hao Yan, Xueqin Chen, Li Ping, Nengming Lin, Bo Yang, Qiaojun He & Peihua Luo. (2022) Autophagic degradation of CCN2 (cellular communication network factor 2) causes cardiotoxicity of sunitinib. Autophagy 18:5, pages 1152-1173.
Read now
Read now
Erhan Ayhan, Özgür Aslan & Eşref Araç. (2021) Effect of isotretinoin (13-cis-retinoic acid) on levels of soluble VEGF receptors (sVEGFR1, sVEGFR2, sVEGFR3) in patients with acne vulgaris. Journal of Dermatological Treatment 32:8, pages 936-940.
Read now
Read now
Luc Heraudet, Charlotte Domblides, Amaury Daste, Félix Lefort, Jean-Christophe Bernhard, Alain Ravaud & Marine Gross-Goupil. (2020) Safety of sunitinib in patients with renal cell carcinoma following nephrectomy. Expert Opinion on Drug Safety 19:7, pages 799-806.
Read now
Read now
Xiaoyan Li, Hongjun Gao, Chuanhao Tang & Xiaoqing Liu. (2016) Oral administration of sunitinib malate for long-term survival of a patient with multiple lung metastases from renal leiomyosarcoma. OncoTargets and Therapy 9, pages 4753-4756.
Read now
Read now
Andrii Anatoliyovych Gryshchenko, Kostiantyn Vasyliovych Levchenko, Volodymyr Grygorovich Bdzhola, Tatiana Panasivna Ruban, Lyubov Leonidovna Lukash & Sergiy Mikolayovych Yarmoluk. (2015) Design, synthesis and biological evaluation of naphthostyril derivatives as novel protein kinase FGFR1 inhibitors. Journal of Enzyme Inhibition and Medicinal Chemistry 30:1, pages 126-132.
Read now
Read now
Adriana Zámečníkova. (2014) Novel approaches to the development of tyrosine kinase inhibitors and their role in the fight against cancer. Expert Opinion on Drug Discovery 9:1, pages 77-92.
Read now
Read now
Umberto Leone Roberti Maggiore, Mario Valenzano Menada, Pier Luigi Venturini & Simone Ferrero. (2013) The potential of sunitinib as a therapy in ovarian cancer. Expert Opinion on Investigational Drugs 22:12, pages 1671-1686.
Read now
Read now
Elena Geuna, Andrea Milani, Stefania Redana, Valentina Rossi, Giorgio Valabrega, Massimo Aglietta & Filippo Montemurro. (2011) Hitting multiple targets in HER2-positive breast cancer: proof of principle or therapeutic opportunity?. Expert Opinion on Pharmacotherapy 12:4, pages 549-565.
Read now
Read now
Keith Laderoute, Joy M. Calaoagan, Peter B. Madrid, Anthony E. Klon & Paula J. Ehrlich. (2010) SU11248 (sunitinib) directly inhibits the activity of mammalian 5'-AMP-activated protein kinase (AMPK). Cancer Biology & Therapy 10:1, pages 68-76.
Read now
Read now
Articles from other publishers (80)
Reshma Murali & Abilash Valsala Gopalakrishnan. (2023) Molecular insight into renal cancer and latest therapeutic approaches to tackle it: an updated review. Medical Oncology 40:12.
Crossref
Crossref
Qian Zhong, Xina Xiao, Yijie Qiu, Zhiqiang Xu, Chunyu Chen, Baochen Chong, Xinjun Zhao, Shan Hai, Shuangqing Li, Zhenmei An & Lunzhi Dai. (2023) Protein posttranslational modifications in health and diseases: Functions, regulatory mechanisms, and therapeutic implications. MedComm 4:3.
Crossref
Crossref
Ling Qiao, Siyuan Qin, Ningna Weng, Bowen Li, Maochao Luo, Zhe Zhang, Li Zhou, Dong Wang & Canhua Huang. (2023) Discovery of canine drug toceranib phosphate as a repurposed agent against human hepatocellular carcinoma. Liver International 43:4, pages 928-944.
Crossref
Crossref
Yipeng Pang, Yushi Wang, Xinyu Zhou, Zhu Ni, Wenjing Chen, Yi Liu & Wenlong Du. (2023) Cuproptosis-Related LncRNA-Based Prediction of the Prognosis and Immunotherapy Response in Papillary Renal Cell Carcinoma. International Journal of Molecular Sciences 24:2, pages 1464.
Crossref
Crossref
Surya K. De. 2023. Medicines for Cancer. Medicines for Cancer
205
411
.
Fatima Ezzahra Bennani, Khalid Karrouchi, Latifa Doudach, Mario Scrima, Noor Rahman, Luca Rastrelli, Trina Ekawati Tallei, Christopher E. Rudd, My El Abbes Faouzi & M’hammed Ansar. (2022) In Silico Identification of Promising New Pyrazole Derivative-Based Small Molecules for Modulating CRMP2, C-RAF, CYP17, VEGFR, C-KIT, and HDAC—Application towards Cancer Therapeutics. Current Issues in Molecular Biology 44:11, pages 5312-5351.
Crossref
Crossref
Olívia Pontes, Sofia Oliveira-Pinto, Fátima Baltazar & Marta Costa. (2022) Renal cell carcinoma therapy: Current and new drug candidates. Drug Discovery Today 27:1, pages 304-314.
Crossref
Crossref
Sangmin Jung, Hyeonsu Jo, Sujin Hyung & Noo Li Jeon. 2022. Microfluidics and Biosensors in Cancer Research. Microfluidics and Biosensors in Cancer Research
231
256
.
Yan Wang, Hong Wu & Ran Deng. (2021) Angiogenesis as a potential treatment strategy for rheumatoid arthritis. European Journal of Pharmacology 910, pages 174500.
Crossref
Crossref
Bhushan D. Varpe, Amol A. Kulkarni, Shailaja B. Jadhav, Anil S. Mali & Shravan Y. Jadhav. (2021) Isatin Hybrids and Their Pharmacological Investigations. Mini-Reviews in Medicinal Chemistry 21:10, pages 1182-1225.
Crossref
Crossref
Mohsen Padervand, Shima Naseri & Sima Hajiahmadi. (2020) Preferential solvation and solvation shell composition of sunitinib malate, an anti-tumor compound, in some binary mixed solvents at 298.15 K. Chemical Papers 75:3, pages 939-950.
Crossref
Crossref
Roma Ghai, M.A. Sheela, Lovenesh Kumar, Abhishek Sharma, Aman Jain & K. Nagarajan. (2021) Evolving insight of adverse drug reaction associated with breast cancer drugs. Materials Today: Proceedings 47, pages 70-75.
Crossref
Crossref
Judith Jing Wen Wong, Maria Brandal Berstad, Ane Sofie Viset Fremstedal, Kristian Berg, Sebastian Patzke, Vigdis Sørensen, Qian Peng, Pål Kristian Selbo & Anette Weyergang. (2020) Photochemically-Induced Release of Lysosomal Sequestered Sunitinib: Obstacles for Therapeutic Efficacy. Cancers 12:2, pages 417.
Crossref
Crossref
Huizhong Li, Jiage Ding, Mengmeng Lu, Hongyan Liu, Yangna Miao, Liantao Li, Gang Wang, Junnian Zheng, Dongsheng Pei & Qing Zhang. (2020) CAIX-specific CAR-T Cells and Sunitinib Show Synergistic Effects Against Metastatic Renal Cancer Models. Journal of Immunotherapy 43:1, pages 16-28.
Crossref
Crossref
Binayak Kumar, Deepu Sharma, Jyotsna Gorantala & Sri Krishna Jayadev Magani. 2020. Novel therapeutic approaches for gastrointestinal malignancies. Novel therapeutic approaches for gastrointestinal malignancies
43
57
.
Anastasia Vedenko, Kush Panara, Gabriella Goldstein, Ranjith Ramasamy & Himanshu Arora. 2020. Tumor Microenvironment. Tumor Microenvironment
143
158
.
Changwei Chen & Sunliang Cui. (2019) Iterative Assembly of Nitrile Oxides and Ynamides: Synthesis of Isoxazoles and Pyrroles. The Journal of Organic Chemistry 84:18, pages 12157-12164.
Crossref
Crossref
Lei Luo, Ye Liang, Xuemei Ding, Xiaocheng Ma, Guiming Zhang & Lijiang Sun. (2019) Significance of cyclooxygenase‑2, prostaglandin E2 and CD133 levels in sunitinib‑resistant renal cell carcinoma. Oncology Letters.
Crossref
Crossref
Juan D. Rojas, Virginie Papadopoulou, Tomasz J. Czernuszewicz, Rajalekha M. Rajamahendiran, Anna Chytil, Yun-Chen Chiang, Diana C. Chong, Victoria L. Bautch, W. Kimryn Rathmell, Stephen Aylward, Ryan C. Gessner & Paul A. Dayton. (2019) Ultrasound Measurement of Vascular Density to Evaluate Response to Anti-Angiogenic Therapy in Renal Cell Carcinoma. IEEE Transactions on Biomedical Engineering 66:3, pages 873-880.
Crossref
Crossref
Patrycja Nowak-Sliwinska, Judy R. van Beijnum, Elisabeth J. M. Huijbers, Paula C. Gasull, Laurie Mans, Axel Bex & Arjan W. Griffioen. (2018) Oncofoetal insulin receptor isoform A marks the tumour endothelium; an underestimated pathway during tumour angiogenesis and angiostatic treatment. British Journal of Cancer 120:2, pages 218-228.
Crossref
Crossref
Roser Pons-Cursach & Oriol Casanovas. 2019. Tumor Angiogenesis. Tumor Angiogenesis
183
208
.
M. V. Zabelin, S. S. Gordeev, S. O. Kochkina, A. A. Kostin, A. A. Fedenko, L. O. Petrov & E. V. Gameeva. (2018) New therapeutic agents for metastatic colorectal cancer: literature review. Colorectal Oncology 8:4, pages 34-46.
Crossref
Crossref
Yuan Ling, Qing Xie, Zikang Zhang & Hua Zhang. (2018) Protein kinase inhibitors for acute leukemia. Biomarker Research 6:1.
Crossref
Crossref
Hideaki Miyake, Yuto Matsushita, Hiromitsu Watanabe, Keita Tamura, Takahisa Suzuki, Daisuke Motoyama, Toshiki Ito, Takayuki Sugiyama & Atsushi Otsukav. (2018) Significance of introduction of alternative dosing schedule for sunitinib during first-line treatment of patients with metastatic renal cell carcinoma. Medical Oncology 35:10.
Crossref
Crossref
Hosni A. M. Hussein, Ikenna B. Okafor, Lia R. Walker, Usama M. Abdel-Raouf & Shaw M. Akula. (2018) Cellular and viral oncogenes: the key to unlocking unknowns of Kaposi’s sarcoma-associated herpesvirus pathogenesis. Archives of Virology 163:10, pages 2633-2643.
Crossref
Crossref
Shailee Tiwari, Nawaz Sharif, Rekha Gajare, Julio Vazquez, Jaiprakash Sangshetti, Manoj Damale & Anna Nikalje. (2018) New 2-Oxoindolin Phosphonates as Novel Agents to Treat Cancer: A Green Synthesis and Molecular Modeling. Molecules 23:8, pages 1981.
Crossref
Crossref
Emiliya V. Nosova, Galina N. Lipunova, Valery N. Charushin & Oleg N. Chupakhin. (2018) Fluorine-containing indoles: Synthesis and biological activity. Journal of Fluorine Chemistry 212, pages 51-106.
Crossref
Crossref
Iratxe Zuazo-Gaztelu & Oriol Casanovas. (2018) Unraveling the Role of Angiogenesis in Cancer Ecosystems. Frontiers in Oncology 8.
Crossref
Crossref
Weijing Sun & Roniel Cabrera. (2018) Systemic Treatment of Patients with Advanced, Unresectable Hepatocellular Carcinoma: Emergence of Therapies. Journal of Gastrointestinal Cancer 49:2, pages 107-115.
Crossref
Crossref
Chandrasekar Balachandran, Jebiti Haribabu, Kumaramangalam Jeyalakshmi, Nattamai S.P. Bhuvanesh, Ramasamy Karvembu, Nobuhiko Emi & Suresh Awale. (2018) Nickel(II) bis(isatin thiosemicarbazone) complexes induced apoptosis through mitochondrial signaling pathway and G0/G1 cell cycle arrest in IM-9 cells. Journal of Inorganic Biochemistry 182, pages 208-221.
Crossref
Crossref
Yuanyuan Zhang, Haixing Mai, Gang Guo, Guofang Bi, Guangtao Hao, Yuanyuan Li, Xiaofang Wang, Longmei Cheng, Jing Wang, Ruihua Dong, Zeyuan Liu, Lijun Chen & Hengyan Qu. (2018) Association analysis of SNPs present in plasma with adverse events and population pharmacokinetics in Chinese sunitinib treated patients with renal cell carcinoma. Oncotarget 9:18, pages 14109-14123.
Crossref
Crossref
Juntao Ai, Meng Lv, Xiaohui Li, Zhuo Chen, Gaoyun Hu & Qianbin Li. (2017) Synthesis, anti-lung cancer activity and molecular docking study of 3-methylene-2-oxoindoline-5-carboxamide derivatives. Medicinal Chemistry Research 27:1, pages 161-170.
Crossref
Crossref
Sameh Eid, Samo Turk, Andrea Volkamer, Friedrich Rippmann & Simone Fulle. (2017) KinMap: a web-based tool for interactive navigation through human kinome data. BMC Bioinformatics 18:1.
Crossref
Crossref
Ayesha S. Khan & Daniel E. Frigo. (2017) A spatiotemporal hypothesis for the regulation, role, and targeting of AMPK in prostate cancer. Nature Reviews Urology 14:3, pages 164-180.
Crossref
Crossref
Roser Pons-Cursach & Oriol Casanovas. 2017. Tumor Angiogenesis. Tumor Angiogenesis
1
25
.
Oriol Casanovas & Roser Pons-Cursach. 2017. Tumor Angiogenesis. Tumor Angiogenesis
1
25
.
Zhexuan Lin, Quanwei Zhang & Wenhong Luo. (2016) Angiogenesis inhibitors as therapeutic agents in cancer: Challenges and future directions. European Journal of Pharmacology 793, pages 76-81.
Crossref
Crossref
Junya Furukawa, Hideaki Miyake & Masato Fujisawa. (2016) GLI2 expression levels in radical nephrectomy specimens as a predictor of disease progression in patients with metastatic clear cell renal cell carcinoma following treatment with sunitinib. Molecular and Clinical Oncology.
Crossref
Crossref
Meng-Yao Wang, Zhi-Rui Lin, Yun Cao, Li-Sheng Zheng, Li-Xia Peng, Rui Sun, Dong-Fang Meng, Ping Xie, Jun-Ping Yang, Li Cao, Liang Xu, Bi-Jun Huang & Chao-Nan Qian. (2016) PDZ binding kinase (PBK) is a theranostic target for nasopharyngeal carcinoma: driving tumor growth via ROS signaling and correlating with patient survival. Oncotarget 7:18, pages 26604-26616.
Crossref
Crossref
Cheng-Jeng Tai, Chien-Kai Wang, Chen-Jei Tai, Ching Tzao, Yung-Chang Lien, Chih-Cheng Hsieh, Cheng-I Hsieh, Hong-Cheng Wu, Chih-Hsiung Wu, Chun-Chao Chang, Ray-Jade Chen & Hung-Yi Chiou. (2015) Evaluation of Safety and Efficacy of Salvage Therapy With Sunitinib, Docetaxel (Tyxan) and Cisplatinum Followed by Maintenance Vinorelbine for Unresectable/Metastatic Nonsmall Cell Lung Cancer. Medicine 94:52, pages e2303.
Crossref
Crossref
Anca Maria Cimpean & Marius Raica. (2015) Lymphangiogenesis and Inflammation—Looking for the “Missing Pieces” of the Puzzle. Archivum Immunologiae et Therapiae Experimentalis 63:6, pages 415-426.
Crossref
Crossref
Silvia Salerno, Anna Maria Marini, Giacomo Fornaciari, Francesca Simorini, Concettina La Motta, Sabrina Taliani, Stefania Sartini, Federico Da Settimo, A?da Nelly Garc?a-Arg?ez, Ornella Gia, Sandro Cosconati, Ettore Novellino, Pilar D'Ocon, Anna Fioravanti, Paola Orlandi, Guido Bocci & Lisa Dalla Via. (2015) Investigation of new 2-aryl substituted Benzothiopyrano[4,3-d]pyrimidines as kinase inhibitors targeting vascular endothelial growth factor receptor 2. European Journal of Medicinal Chemistry 103, pages 29-43.
Crossref
Crossref
Guo-Rui Gao, Meng-Yuan Li, Lin-Jiang Tong, Li-Xin Wei, Jian Ding, Hua Xie & Wen-Hu Duan. (2015) Design, synthesis and biological evaluation of O-linked indoles as VEGFR-2 kinase inhibitors (I). Chinese Chemical Letters 26:9, pages 1165-1168.
Crossref
Crossref
Constantinos Alifieris & Dimitrios T. Trafalis. (2015) Glioblastoma multiforme: Pathogenesis and treatment. Pharmacology & Therapeutics 152, pages 63-82.
Crossref
Crossref
C Wu, S Mikhail, L Wei, C Timmers, S Tahiri, A Neal, J Walker, S El-Dika, M Blazer, J Rock, D J Clark, X Yang, J L Chen, J Liu, M V Knopp & T Bekaii-Saab. (2015) A phase II and pharmacodynamic study of sunitinib in relapsed/refractory oesophageal and gastro-oesophageal cancers. British Journal of Cancer 113:2, pages 220-225.
Crossref
Crossref
Masatomo Nishikawa, Hideaki Miyake & Masato Fujisawa. (2015) Enhanced Sensitivity to Sunitinib by Inhibition of Akt1 Expression in Human Castration-resistant Prostate Cancer PC3 Cells Both In Vitro and In Vivo. Urology 85:5, pages 1215.e1-1215.e7.
Crossref
Crossref
Genoveva Morral-Ruíz, Pedro Melgar-Lesmes, Andrea López-Vicente, Conxita Solans & María José García-Celma. (2015) Biotinylated polyurethane-urea nanoparticles for targeted theranostics in human hepatocellular carcinoma. Nano Research 8:5, pages 1729-1745.
Crossref
Crossref
Baisakhi Raychaudhuri, Patricia Rayman, Pengjing Huang, Matthew Grabowski, Dolores Hambardzumyan, James H. Finke & Michael A. Vogelbaum. (2015) Myeloid derived suppressor cell infiltration of murine and human gliomas is associated with reduction of tumor infiltrating lymphocytes. Journal of Neuro-Oncology 122:2, pages 293-301.
Crossref
Crossref
Hideaki Miyake, Ken-ichi Harada, Akira Miyazaki & Masato Fujisawa. (2015) Improved health-related quality of life of patients with metastatic renal cell carcinoma treated with a 2 weeks on and 1 week off schedule of sunitinib. Medical Oncology 32:3.
Crossref
Crossref
P Nowak-Sliwinska, A Weiss, J R van Beijnum, T J Wong, W W Kilarski, G Szewczyk, H M W Verheul, T Sarna, H van den Bergh & A W Griffioen. (2015) Photoactivation of lysosomally sequestered sunitinib after angiostatic treatment causes vascular occlusion and enhances tumor growth inhibition. Cell Death & Disease 6:2, pages e1641-e1641.
Crossref
Crossref
D. S. Novikova, A. V. Garabadzhiu, G. Melino, N. A. Barlev & V. G. Tribulovich. (2015) AMP-activated protein kinase: Structure, function, and role in pathological processes. Biochemistry (Moscow) 80:2, pages 127-144.
Crossref
Crossref
Rishil J. Kathawala, Pranav Gupta, Charles R. AshbyJr.Jr. & Zhe-Sheng Chen. (2015) The modulation of ABC transporter-mediated multidrug resistance in cancer: A review of the past decade. Drug Resistance Updates 18, pages 1-17.
Crossref
Crossref
Elisa Giovannetti & Elena Galvani. 2015. Targeted Therapies for Solid Tumors. Targeted Therapies for Solid Tumors
9
29
.
Chun-Nan Yeh, Wen-Hung Chung, Shih-Chi Su, Yen-Yang Chen, Chi-Tung Cheng, Yen-Ling Lin, Wan-Chun Chang, Rosaline Chung-Yee Hui, Kun-Chun Chiang, Tsung-Wen Chen, Yi-Yin Jan, Chien-Wei Chen, Ting-Jui Chen, Chih-Hsun Yang & Shuen-Iu Hung. (2014) Fas/Fas Ligand Mediates Keratinocyte Death in Sunitinib-Induced Hand-Foot Skin Reaction. Journal of Investigative Dermatology 134:11, pages 2768-2775.
Crossref
Crossref
Yen-Yang Chen, Chun-Nan Yeh, Chi-Tung Cheng, Chao-En Wu, Kun-Chun Chiang, Tsung-Wen Chen, Chih-Chi Wang, Jen-Shi Chen & Ta-Sen Yeh. (2014) Fractioned Dose Regimen of Sunitinib for Patients with Gastrointestinal Stromal Tumor: A Pharmacokinetic and Treatment Efficacy Study. Translational Oncology 7:5, pages 620-625.
Crossref
Crossref
A. Kleger, L. Perkhofer & T. Seufferlein. (2014) Smarter drugs emerging in pancreatic cancer therapy. Annals of Oncology 25:7, pages 1260-1270.
Crossref
Crossref
Hideaki Miyake, Masatomo Nishikawa, Hiromoto Tei, Junya Furukawa, Ken-ichi Harada & Masato Fujisawa. (2014) Significance of circulating matrix metalloproteinase-9 to tissue inhibitor of metalloproteinases-2 ratio as a predictor of disease progression in patients with metastatic renal cell carcinoma receiving sunitinib11This study was partially supported by Pfizer Inc.. Urologic Oncology: Seminars and Original Investigations 32:5, pages 584-588.
Crossref
Crossref
Hyunji Lee, Suhrid Banskota, Dong-Guk Kim, Jae-Hui Been, You-Jin Jin, Jaya Gautam, Hyeonjin Jang, Tae-gyu Nam, Jung-Ae Kim & Byeong-Seon Jeong. (2014) Synthesis and antiangiogenic activity of 6-amido-2,4,5-trimethylpyridin-3-ols. Bioorganic & Medicinal Chemistry Letters 24:14, pages 3131-3136.
Crossref
Crossref
Hideaki Miyake, Akira Miyazaki, Ken-ichi Harada & Masato Fujisawa. (2014) Assessment of efficacy, safety and quality of life of 110 patients treated with sunitinib as first-line therapy for metastatic renal cell carcinoma: experience in real-world clinical practice in Japan. Medical Oncology 31:6.
Crossref
Crossref
A-Young Choi, Ji Hyun Choi, Keun-Young Hwang, Yeon Ju Jeong, Wonchae Choe, Kyung-Sik Yoon, Joohun Ha, Sung Soo Kim, Jang Hyun Youn, Eui-Ju Yeo & Insug Kang. (2013) RETRACTED ARTICLE: Licochalcone A induces apoptosis through endoplasmic reticulum stress via a phospholipase Cγ1-, Ca2+-, and reactive oxygen species-dependent pathway in HepG2 human hepatocellular carcinoma cells. Apoptosis 19:4, pages 682-697.
Crossref
Crossref
Stefania Sartini, Vito Coviello, Agostino Bruno, Valeria La Pietra, Luciana Marinelli, Francesca Simorini, Sabrina Taliani, Silvia Salerno, Anna Maria Marini, Anna Fioravanti, Paola Orlandi, Alessandro Antonelli, Federico Da Settimo, Ettore Novellino, Guido Bocci & Concettina La Motta. (2014)
Structure-Based Optimization of Tyrosine Kinase Inhibitor
CLM3
. Design, Synthesis, Functional Evaluation, and Molecular Modeling Studies.
. Journal of Medicinal Chemistry 57:4, pages 1225-1235.
Crossref
Crossref
Areen K. Al-Bashir, Gilda G. Hillman, Meng Li, Yashwanth Katkuri, Vinita Singh-Gupta, Yimin Shen, Christopher K Yunker & E. Mark Haacke. (2014) New DCE-MRI parameters to quantify the vascular changes induced by sunitinib treatment in renal carcinoma tumors. New DCE-MRI parameters to quantify the vascular changes induced by sunitinib treatment in renal carcinoma tumors.
Hyunji Lee, Dong-Guk Kim, Suhrid Banskota, You Kyoung Lee, Tae-gyu Nam, Jung-Ae Kim & Byeong-Seon Jeong. (2014) Pyridoxine-derived bicyclic amido-, ureido-, and carbamato-pyridinols: synthesis and antiangiogenic activities. Org. Biomol. Chem. 12:43, pages 8702-8710.
Crossref
Crossref
Adrian L. Harris & Daniele Generali. 2014. Cancer Drug Design and Discovery. Cancer Drug Design and Discovery
275
317
.
Giuseppe Aprile, Marta Bonotto, Elena Ongaro, Carmelo Pozzo & Francesco Giuliani. (2013) Critical Appraisal of Ramucirumab (IMC-1121B) for Cancer Treatment: From Benchside to Clinical Use. Drugs 73:18, pages 2003-2015.
Crossref
Crossref
Giuseppe Giaccone & Jean-Charles SoriaSophie Postel-Vinay & Jean-Pierre Armand. 2013. Targeted Therapies in Oncology, Second Edition. Targeted Therapies in Oncology, Second Edition
283
314
.
Renyi Shi, Lijun Lu, Hua Zhang, Borui Chen, Yuchen Sha, Chao Liu & Aiwen Lei. (2013) Palladium/Copper‐Catalyzed Oxidative CH Alkenylation/N‐Dealkylative Carbonylation of Tertiary Anilines. Angewandte Chemie International Edition 52:40, pages 10582-10585.
Crossref
Crossref
Renyi Shi, Lijun Lu, Hua Zhang, Borui Chen, Yuchen Sha, Chao Liu & Aiwen Lei. (2013) Palladium/Copper‐Catalyzed Oxidative CH Alkenylation/N‐Dealkylative Carbonylation of Tertiary Anilines. Angewandte Chemie 125:40, pages 10776-10779.
Crossref
Crossref
Iori Sakai, Hideaki Miyake & Masato Fujisawa. (2013) Acquired resistance to sunitinib in human renal cell carcinoma cells is mediated by constitutive activation of signal transduction pathways associated with tumour cell proliferation. BJU International 112:2, pages E211-E220.
Crossref
Crossref
T. M. Sakr, D. M. El-Safoury, Gehanne A. S. Awad & M. A. Motaleb. (2013)
Biodistribution of
99m
Tc-sunitinib as a potential radiotracer for tumor hypoxia imaging
. Journal of Labelled Compounds and Radiopharmaceuticals 56:8, pages 392-395.
Crossref
Crossref
C. London, T. Mathie, N. Stingle, C. Clifford, S. Haney, M. K. Klein, L. Beaver, K. Vickery, D. M. Vail, B. Hershey, S. Ettinger, A. Vaughan, F. Alvarez, L. Hillman, M. Kiselow, D. Thamm, M. L. Higginbotham, M. Gauthier, E. Krick, B. Phillips, T. LaDue, P. Jones, J. Bryan, V. Gill, A. Novasad, L. Fulton, J. Carreras, C. McNeill, C. Henry & S. Gillings. (2012)
Preliminary evidence for biologic activity of toceranib phosphate (Palladia
®
) in solid tumours
. Veterinary and Comparative Oncology 10:3, pages 194-205.
Crossref
Crossref
Yevgeniy Balagula, Shenhong Wu, Xiao Su, Darren R. Feldman & Mario E. Lacouture. (2011) The risk of hand foot skin reaction to pazopanib, a novel multikinase inhibitor: a systematic review of literature and meta-analysis. Investigational New Drugs 30:4, pages 1773-1781.
Crossref
Crossref
Alexander Kutikov, Peter Makhov, Konstantin Golovine, Daniel J. Canter, Mohit Sirohi, Ryan Street, Jay Simhan, Robert G. Uzzo & Vladimir M. Kolenko. (2011) Interleukin-6: A Potential Biomarker of Resistance to Multitargeted Receptor Tyrosine Kinase Inhibitors in Castration-resistant Prostate Cancer. Urology 78:4, pages 968.e7-968.e11.
Crossref
Crossref
Mark A. Eckert & Jing Yang. (2011) Targeting invadopodia to block breast cancer metastasis. Oncotarget 2:7, pages 562-568.
Crossref
Crossref
Jonathan Trent & Mathieu Molimard. (2011) Pharmacokinetics and Pharmacodynamics of Nilotinib in Gastrointestinal Stromal Tumors. Seminars in Oncology 38, pages S28-S33.
Crossref
Crossref
. 2011. Tumor hypoxia in the clinical setting. Tumor hypoxia in the clinical setting.
Satoru Takahashi. (2011) Vascular Endothelial Growth Factor (VEGF), VEGF Receptors and Their Inhibitors for Antiangiogenic Tumor Therapy. Biological & Pharmaceutical Bulletin 34:12, pages 1785-1788.
Crossref
Crossref
Raúl Catena, Diego Luis-Ravelo, Iker Antón, Carolina Zandueta, Pablo Salazar-Colocho, Leyre Larzábal, Alfonso Calvo & Fernando Lecanda. (2011) PDGFR Signaling Blockade in Marrow Stroma Impairs Lung Cancer Bone Metastasis. Cancer Research 71:1, pages 164-174.
Crossref
Crossref
Deborah Mukherji, James Larkin & Lisa Pickering. (2010) Sunitinib for metastatic renal cell carcinoma. Future Oncology 6:9, pages 1377-1385.
Crossref
Crossref
Georgios Giamas, Yik L. Man, Heidrun Hirner, Joachim Bischof, Klaus Kramer, Kalimullah Khan, Sharmeen S. Lavina Ahmed, Justin Stebbing & Uwe Knippschild. (2010) Kinases as targets in the treatment of solid tumors. Cellular Signalling 22:7, pages 984-1002.
Crossref
Crossref